The rat 5-hydroxytryptamine1B receptor is the species homologue of the human 5-hydroxytryptamine1D beta receptor
Adham, N.; Romanienko, P.; Hartig, P.; Weinshank, R.L.; Branchek, T.
Molecular Pharmacology 41(1): 1-7
1992
ISSN/ISBN: 0026-895X PMID: 1732711 Document Number: 394742
Document emailed within 1 workday
Related Documents
Pinto, W.; Battaglia, G. 1994: Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation Molecular Pharmacology 46(6): 1111-1119Clancy, B.M.; Maayani, S. 1985: 5-Hydroxytryptamine receptor in isolated rabbit aorta: characterization with tryptamine analogs Journal of Pharmacology and Experimental Therapeutics 233(3): 761-769
Czyrak, A.; Skuza, G.; Rogóz, Z.; Frankiewicz, T.; Maj, J. 1994: Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes Arzneimittel-Forschung 44(2): 113-118
Zebrowska-Lupina, I. 1976: The effect of noradrenergic receptor blocking agents on 5-hydroxytryptamine turnover in the brain of rats Polish Journal of Pharmacology and Pharmacy 28(4): 341-347
Linden, A.S.; Desmecht, D.J.; Amory, H.; Rollin, F.A.; Michaux, C.L.; Lekeux, P. 1993: Pulmonary response to intravenous administration of 5-hydroxytryptamine after type-2 receptor blockade in healthy calves American Journal of Veterinary Research 54(1): 168-173
Ollivier, Y.; Chauvel, Y.; Samperez, S.; Jouan, P. 1975: Plasma transport of 5-hydroxytryptamine-3H. I. Nature and classification of indole derivatives after injection of 5-hydroxytryptamine-3H Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 169(2): 408-412
Roth, B.L.; Craigo, S.C.; Choudhary, M.S.; Uluer, A.; Monsma, F.J.; Shen, Y.; Meltzer, H.Y.; Sibley, D.R. 1994: Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors Journal of Pharmacology and Experimental Therapeutics 268(3): 1403-1410
Endo, T.; Ogawa, T.; Hamaue, N.; Akita, K.; Hirafuji, M.; Minami, M.; Blower, P.R. 1998: Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets Research Communications in Molecular Pathology and Pharmacology 100(3): 243-253
Odagaki, Y.; Fuxe, K. 1995: Pharmacological characterization of the 5-hydroxytryptamine-1A receptor-mediated activation of high-affinity GTP hydrolysis in rat hippocampal membranes Journal of Pharmacology and Experimental Therapeutics 274(1): 337-344
Endo, T.; Hamaue, N.; Ihira, E.; Teramoto, Y.; Liu, Y.; Hirafuji, M.; Minami, M. 2002: Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model Research Communications in Molecular Pathology and Pharmacology 111(1-4): 55-68
McCreary, A.C.; Bankson, M.G.; Cunningham, K.A. 1999: Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors Journal of Pharmacology and Experimental Therapeutics 290(3): 965-973
Seong, Y.H.; Baba, A.; Matsuda, T.; Iwata, H. 1990: 5-Hydroxytryptamine modulation of electrically induced twitch responses of mouse vas deferens: involvement of multiple 5-hydroxytryptamine receptors Journal of Pharmacology and Experimental Therapeutics 254(3): 1012-1016
Cohen, M.L.; Robertson, D.W.; Bloomquist, W.E.; Wilson, H.C. 1992: LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis Journal of Pharmacology and Experimental Therapeutics 261(1): 202-208
Angelis, L.; Predominato, M.; Vertua, R. 1975: 5-Hydroxytryptamine-14C and dexamphetamine-14C uptake by fundal sarcolemma preparations: effect of thermal and chemical alterations as indirect approach to the problem of the common receptor Archives Internationales de Pharmacodynamie et de Therapie 216(1): 51-56
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Williams, J.; Spurlock, G.; McGuffin, P.; Mallet, J.; Nöthen, M.M.; Gill, M.; Aschauer, H.; Nylander, P.O.; Macciardi, F.; Owen, M.J. 1996: Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group Lancet 347(9011): 1294-1296
Stacker, S.A.; Hovens, C.M.; Vitali, A.; Pritchard, M.A.; Baker, E.; Sutherland, G.R.; Wilks, A.F. 1993: Molecular cloning and chromosomal localisation of the human homologue of a receptor related to tyrosine kinases (RYK) Oncogene 8(5): 1347-1356
Avner, B.P.; Noland, B. 1978: Desensitization to beta-receptor mediated bronchodilator drugs in the rat: decreased beta-receptor affinity Proceedings of the Western Pharmacology Society 21: 175-181
Hattori, M.; Okazaki, H.; Ishida, Y.; Onuma, M.; Kano, S.; Honjo, T.; Minato, N. 1990: Expression of murine IL-2 receptor beta-chain on thymic and splenic lymphocyte subpopulations as revealed by the IL-2-induced proliferative response in human IL-2 receptor alpha-chain transgenic mice Journal of Immunology 144(10): 3809-3815
Kocur, J.; Jurkowski, A.; Kedziora, J.; Czernicki, J.; Kedziora, H. 1975: The influence of 5-hydroxytryptamine and some beta-adrenolytic compounds on adenylylcyclase in rabbit brain in vitro Polish Journal of Pharmacology and Pharmacy 27(Suppl): 113-117